NCT01995058 2026-01-08Combo of Cabozantinib With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic CRPCExelixisPhase 2 Terminated54 enrolled 11 charts
NCT02711137 2025-10-21Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced MalignanciesIncyte CorporationPhase 1/2 Terminated137 enrolled 31 charts
NCT04291664 2024-10-17PK and Dose Escalation and Expansion Study of DST-2970DisperSol Technologies, LLCPhase 1 Terminated26 enrolled
NCT05084859 2024-08-09A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Orally Administered SM08502 Combined With Hormonal Therapy or Chemotherapy in Subjects With Advanced Solid TumorsBiosplice Therapeutics, Inc.Phase 1 Terminated30 enrolled